IliAD Biotechnologies' Unattributed - II Round

IliAD Biotechnologies raised a round of funding on August 12, 2016.

ILiAD Biotechnologies (ILiAD) is a clinical stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis. ILiAD's lead candidate is BPZE1, a live-atten…

Articles about IliAD Biotechnologies' Unattributed - II Round: